identified elevated PTX3 levels in both the breast tumor microenvironment (TME) and bone microenvironment, where it facilitates the transition of epithelial cells with mesenchymal features into breast osteoblast-like cells, enhancing tumor aggressiveness (65). The gene discussed is PTX3; the disease is breast neoplasm.